HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dusan Hirjak Selected Research

Silver Sulfadiazine (SSD)

9/2022Characterizing the sensorimotor domain in schizophrenia spectrum disorders.
5/2022Structural alterations of amygdala and hypothalamus contribute to catatonia.
12/2021Progress in sensorimotor neuroscience of schizophrenia spectrum disorders: Lessons learned and future directions.
12/2021Intrinsic neural network dynamics in catatonia.
12/2021Structural alterations in brainstem, basal ganglia and thalamus associated with parkinsonism in schizophrenia spectrum disorders.
1/2021White matter microstructure alterations in cortico-striatal networks are associated with parkinsonism in schizophrenia spectrum disorders.
10/2020Brainstem alterations contribute to catatonia in schizophrenia spectrum disorders.
1/2020Multimodal Magnetic Resonance Imaging Data Fusion Reveals Distinct Patterns of Abnormal Brain Structure and Function in Catatonia.
1/2020A Neural Signature of Parkinsonism in Patients With Schizophrenia Spectrum Disorders: A Multimodal MRI Study Using Parallel ICA.
1/2020Neurological soft signs in schizophrenia spectrum disorders are not confounded by current antipsychotic dosage.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dusan Hirjak Research Topics

Disease

24Schizophrenia (Dementia Praecox)
09/2022 - 01/2015
11Catatonia
09/2022 - 10/2019
5Parkinsonian Disorders (Parkinsonism)
09/2022 - 01/2020
4Mental Disorders (Mental Disorder)
03/2022 - 02/2013
4Psychotic Disorders (Schizoaffective Disorder)
01/2022 - 01/2019
3Movement Disorders (Movement Disorder)
12/2021 - 01/2020
2Psychomotor Agitation (Akathisia)
09/2022 - 01/2020
2Pathologic Processes
04/2016 - 02/2015
1Tardive Dyskinesia
09/2022
1Neuroleptic Malignant Syndrome
11/2021
1Dyskinesias (Dyskinesia)
01/2020
1Autism Spectrum Disorder
06/2018
1Paraplegia (Spastic Paraplegia)
02/2013
1Wounds and Injuries (Trauma)
10/2012
1Intraoperative Complications
10/2012
1Osteoarthritis
03/2011

Drug/Important Bio-Agent (IBA)

14Silver Sulfadiazine (SSD)FDA LinkGeneric
09/2022 - 01/2019
9Antipsychotic Agents (Antipsychotics)IBA
11/2021 - 01/2015
3Pharmaceutical PreparationsIBA
05/2017 - 03/2011
1AmphetaminesIBA
01/2022
1Hallucinogens (Psychedelics)IBA
01/2022
1Clozapine (Clozaril)FDA LinkGeneric
01/2021
1Biological ProductsIBA
01/2021
1GABA AgentsIBA
01/2020
1Dopamine (Intropin)FDA LinkGeneric
01/2020
1gamma-Aminobutyric Acid (GABA)IBA
10/2019
1Polytetrafluoroethylene (Teflon)FDA Link
01/2019
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
03/2011
1Analgesics (Analgesic Drugs)IBA
03/2011

Therapy/Procedure

8Therapeutics
03/2022 - 03/2011
2Endurance Training
10/2021 - 03/2021
1Telescopes
12/2019
1Epidural Anesthesia
02/2013
1Prostheses and Implants (Prosthesis)
10/2012
1Splints (Splint)
03/2011
1Induced Hyperthermia (Thermotherapy)
03/2011